G. Kalsi Et Al. , "THE EFFICACY AND SAFETY OF GENETICALLY ENGINEERED ALLOGENEIC HUMAN CHONDROCYTES EXPRESSING TGF-β1 IN PATIENTS WITH GRADE 3 CHRONIC DEGENERATIVE JOINT DISEASE OF THE KNEE," OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis , Liverpool, England, 2018
Kalsi, G. Et Al. 2018. THE EFFICACY AND SAFETY OF GENETICALLY ENGINEERED ALLOGENEIC HUMAN CHONDROCYTES EXPRESSING TGF-β1 IN PATIENTS WITH GRADE 3 CHRONIC DEGENERATIVE JOINT DISEASE OF THE KNEE. OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis , (Liverpool, England).
Kalsi, G., PARVİZİ, J., Bramlet, D., Romness, D., Guermazi, A., Noh, M., ... Khlopas, A.(2018). THE EFFICACY AND SAFETY OF GENETICALLY ENGINEERED ALLOGENEIC HUMAN CHONDROCYTES EXPRESSING TGF-β1 IN PATIENTS WITH GRADE 3 CHRONIC DEGENERATIVE JOINT DISEASE OF THE KNEE . OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, Liverpool, England
Kalsi, G. Et Al. "THE EFFICACY AND SAFETY OF GENETICALLY ENGINEERED ALLOGENEIC HUMAN CHONDROCYTES EXPRESSING TGF-β1 IN PATIENTS WITH GRADE 3 CHRONIC DEGENERATIVE JOINT DISEASE OF THE KNEE," OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, Liverpool, England, 2018
Kalsi, G. Et Al. "THE EFFICACY AND SAFETY OF GENETICALLY ENGINEERED ALLOGENEIC HUMAN CHONDROCYTES EXPRESSING TGF-β1 IN PATIENTS WITH GRADE 3 CHRONIC DEGENERATIVE JOINT DISEASE OF THE KNEE." OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis , Liverpool, England, 2018
Kalsi, G. Et Al. (2018) . "THE EFFICACY AND SAFETY OF GENETICALLY ENGINEERED ALLOGENEIC HUMAN CHONDROCYTES EXPRESSING TGF-β1 IN PATIENTS WITH GRADE 3 CHRONIC DEGENERATIVE JOINT DISEASE OF THE KNEE." OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis , Liverpool, England.
@conferencepaper{conferencepaper, author={G. Kalsi Et Al. }, title={THE EFFICACY AND SAFETY OF GENETICALLY ENGINEERED ALLOGENEIC HUMAN CHONDROCYTES EXPRESSING TGF-β1 IN PATIENTS WITH GRADE 3 CHRONIC DEGENERATIVE JOINT DISEASE OF THE KNEE}, congress name={OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis}, city={Liverpool}, country={England}, year={2018}}